The inability of vaccinia virus A33R protein to form intermolecular disulfide-bonded homodimers does not affect the production of infectious extracellular virus

Virology

Volumn 408, Issue 1, 2010, Pages 109-118

  Chan, Winnie M ^a   Kalkanoglu, Aja E ^a   Ward, Brian M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

A33R; Intermolecular disulfide bond; Morphogenesis; Vaccinia virus

Indexed keywords

A33R PROTEIN; CYSTEINE; HOMODIMER; SERINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DIMERIZATION; DISULFIDE BOND; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; POXVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; VACCINIA VIRUS; VIROGENESIS; VIRUS MORPHOGENESIS; VIRUS RECOMBINANT;

CYSTEINE; DISULFIDES; HELA CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MUTAGENESIS, SITE-DIRECTED; PLAQUE ASSAY; PROTEIN MULTIMERIZATION; SERINE; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL LOAD; VIRUS ASSEMBLY; VIRUS REPLICATION;

ORTHOPOXVIRUS; VACCINIA VIRUS;

EID: 78049251317     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.09.021     Document Type: Article

References (42)

1. Appleyard G., Hapel A.J., Boulter E.A. An antigenic difference between intracellular and extracellular rabbitpox virus. J. Gen. Virol. 1971, 13:9-17.
2. Blasco R., Moss B. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein. J. Virol. 1991, 65(11):5910-5920.
3. Buchman G.W., Cohen M.E., Xiao Y., Richardson-Harman N., Silvera P., Detolla L.J., Davis H.L., Eisenberg R.J., Cohen G.H., Isaacs S.N. A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge. Vaccine 2010, 28(40):6627-6636.
4. Chan W.M., Ward B.M. There is an A33-dependent mechanism for the incorporation of B5-GFP into vaccinia virus extracellular enveloped virions. Virology 2010, 402(1):83-93.
5. Chen Z., Earl P., Americo J., Damon I., Smith S.K., Yu F., Sebrell A., Emerson S., Cohen G., Eisenberg R.J., Gorshkova I., Schuck P., Satterfield W., Moss B., Purcell R. Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model. J. Virol. 2007, 81(17):8989-8995.
6. Duncan S.A., Smith G.L. Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. J. Virol. 1992, 66:1610-1621.
7. Earl P.L., Moss B. Generation of recombinant vaccinia viruses. Current Protocols in Molecular Biology 1991, Vol. 2. Greene Publishing Associates & Wiley Interscience, New York, 16.17.1-16.17.16.
8. Earley A.K., Chan W.M., Ward B.M. The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions. J. Virol. 2008, 82(5):2161-2169.
9. Engelstad M., Howard S.T., Smith G.L. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 1992, 188:801-810.
10. Fang M., Cheng H., Dai Z., Bu Z., Sigal L.J. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host. Virology 2006, 345(1):231-243.
11. Fogg C., Lustig S., Whitbeck J.C., Eisenberg R.J., Cohen G.H., Moss B. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions. J. Virol. 2004, 78(19):10230-10237.
12. Geada M.M., Galindo I., Lorenzo M.M., Perdiguero B., Blasco R. Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein. J. Gen. Virol. 2001, 82(Pt 11):2747-2760.
13. Golden J.W., Hooper J.W. Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine. Virology 2008, 377(1):19-29.
14. Grosenbach D.W., Hansen S.G., Hruby D.E. Identification and analysis of vaccinia virus palmitylproteins. Virology 2000, 275(1):193-206.
15. Hiller G., Weber K. Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment. J. Virol. 1985, 55(3):651-659.
16. Hollinshead M., Rodger G., Van Eijl H., Law M., Hollinshead R., Vaux D.J., Smith G.L. Vaccinia virus utilizes microtubules for movement to the cell surface. J. Cell Biol. 2001, 154(2):389-402.
17. Hooper J.W., Custer D.M., Schmaljohn C.S., Schmaljohn A.L. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge. Virology 2000, 266(2):329-339.
18. Hooper J.W., Custer D.M., Thompson E. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology 2003, 306(1):181-195.
19. Hooper J.W., Thompson E., Wilhelmsen C., Zimmerman M., Ichou M.A., Steffen S.E., Schmaljohn C.S., Schmaljohn A.L., Jahrling P.B. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J. Virol. 2004, 78(9):4433-4443.
20. Isaacs S.N., Wolffe E.J., Payne L.G., Moss B. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. J. Virol. 1992, 66(12):7217-7224.
21. Lawrence S.J., Lottenbach K.R., Newman F.K., Buller R.M., Bellone C.J., Chen J.J., Cohen G.H., Eisenberg R.J., Belshe R.B., Stanley S.L., Frey S.E. Antibody responses to vaccinia membrane proteins after smallpox vaccination. J. Infect. Dis. 2007, 196(2):220-229.
22. McIntosh A.A., Smith G.L. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J. Virol. 1996, 70(1):272-281.
23. Moss, B. (2001). Poxviridae: The viruses and their replication. Fourth ed. In "Fields Virology" (B. N. Fields, D. M. Knipe, and P. M. Howley, Eds.), Vol. 2, pp. 2849-2883. 2 vols. Lippincott-Raven Publishers, Philadelphia.
24. Payne L.G. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J. Gen. Virol. 1980, 50(1):89-100.
25. Payne L.G. Characterization of vaccinia virus glycoproteins by monoclonal antibody preparations. Virology 1992, 187:251-260.
26. Perdiguero B., Blasco R. Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins. J. Virol. 2006, 80(17):8763-8777.
27. Rietdorf J., Ploubidou A., Reckmann I., Holmstrom A., Frischknecht F., Zettl M., Zimmermann T., Way M. Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus. Nat. Cell Biol. 2001, 3(11):992-1000.
28. Roper R.L., Payne L.G., Moss B. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J. Virol. 1996, 70(6):3753-3762.
29. Roper R.L., Wolffe E.J., Weisberg A., Moss B. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J. Virol. 1998, 72(5):4192-4204.
30. Schmelz M., Sodeik B., Ericsson M., Wolffe E.J., Shida H., Hiller G., Griffiths G. Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J. Virol. 1994, 68(1):130-147.
31. Smith G.L., Vanderplasschen A., Law M. The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 2002, 83(Pt 12):2915-2931.
32. Su H.P., Singh K., Gittis A.G., Garboczi D.N. The structure of the poxvirus A33 protein reveals a dimer of unique C-type lectin-like domains. J. Virol. 2010, 84(5):2502-2510.
33. Tooze J., Hollinshead M., Reis B., Radsak K., Kern H. Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur. J. Cell Biol. 1993, 60(1):163-178.
34. van Eijl H., Hollinshead M., Smith G.L. The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology 2000, 271(1):26-36.
35. van Eijl H., Hollinshead M., Rodger G., Zhang W.H., Smith G.L. The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J. Gen. Virol. 2002, 83(Pt 1):195-207.
36. Wagenaar T.R., Moss B. Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex. J. Virol. 2007, 81(12):6286-6293.
37. Ward B.M. Visualization and characterization of the intracellular movement of vaccinia virus intracellular mature virions. J. Virol. 2005, 79:4755-4763.
38. Ward B.M., Moss B. Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein. J. Virol. 2000, 74(8):3771-3780.
39. Ward B.M., Moss B. Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails. J. Virol. 2001, 75(23):11651-11663.
40. Ward B.M., Moss B. Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera. J. Virol. 2001, 75(10):4802-4813.
41. Ward B.M., Weisberg A.S., Moss B. Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins. J. Virol. 2003, 77(7):4113-4126.
42. Wolffe E.J., Weisberg A.S., Moss B. The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein. J. Virol. 2001, 75(1):303-310.